Live from the NIH registry
Studies recruiting near Gulfport right now
Top 25 of 35 recruiting studies, sorted by proximity — each links to its official registry page
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
DelRicht Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: Kallyope Inc.
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Dynamed Clinical Research, LP d/b/a DM Clinical Research — Gulfport, Mississippi (4.4 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Pfizer
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Ardelyx
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: NRG Oncology
Tissue Repair Gel in Venous Leg Ulcers (US)
Venous Leg Ulcer, Venous Ulcer
Phase 3
Interventional 312 participants sought
Clincial Research Site 07 — D'Iberville, Mississippi (10.7 mi)
· Sponsor: TR Therapeutics
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Acute Gouty Arthritis, Gout Flare
Phase 2
Interventional 380 participants sought
DelRicht Research Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Atom Therapeutics Co., Ltd
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8
Phase 2
Interventional 2,900 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: National Cancer Institute (NCI)
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
STRIVE Post-Market Registry Study
Emphysema
N/A
Observational 150 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Olympus Corporation of the Americas
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Lung Cancer Diagnosis
N/A
Observational 20,000 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Freenome Holdings Inc.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Boehringer Ingelheim
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: National Cancer Institute (NCI)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
DelRicht Research at Gulfport Memorial — Gulfport, Mississippi (4.4 mi)
· Sponsor: Hoffmann-La Roche
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Gulfport, Mississippi (4.4 mi)
· Sponsor: AstraZeneca
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Singing River Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Stryker Instruments
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
Lung Cancer Screening
N/A
Interventional 200 participants sought
Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Timothy Mullett
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Respiratory Distress Syndrome, Acute
Phase 2
Interventional 52 participants sought
Ocean Springs Hospital — Ocean Springs, Mississippi (14.5 mi)
· Sponsor: GEn1E Lifesciences
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research - Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Hawthorne Health — Diamondhead, Mississippi (17.6 mi)
· Sponsor: Novo Nordisk A/S
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
NeuroSpecs-Gulfport Performance Spine — Gulfport, Mississippi (4.4 mi)
· Sponsor: Boston Scientific Corporation
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Memorial Hospital at Gulfport — Gulfport, Mississippi (4.4 mi)
· Sponsor: United Therapeutics